(esketamine)
This information is intended for US patients and caregivers to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended to promote the use of our products, nor to provide medical advice.
SPRAVATO® (esketamine)
Patient Medical Information
Can I use SPRAVATO with COVID-19 Vaccines?
Last Updated: 06/21/2023
summary
Use with COVID-19 Vaccines
- There is currently no public information available for the use of SPRAVATO with COVID-19 Vaccines.1
How can I learn more?
- Ask your vaccination provider.
- Visit Centers for Disease Control and Prevention (CDC) at https://www.cdc.gov/coronavirus/2019-ncov/index.html.
- Visit FDA at https://www.fda.gov/emergency-preparedness-and-response/mcm-legal- regulatory-and-policy-framework/emergency-use-authorization.
- Contact your local or state public health department.
This information is provided ONLY in response to your request and is not intended as medical advice, to promote the use of our product, or suggest using it in any manner other than as described in the PRESCRIBING INFORMATION. All decisions regarding your medical treatment should be made with your healthcare professional(s). Please contact your healthcare professional(s) to discuss the information in this response.
Please refer to the attached full PRESCRIBING INFORMATION and the PATIENT MEDICATION GUIDE for SPRAVATO.1
References
| 1 | SPRAVATO (esketamine nasal spray) [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc; https://imedicalknowledge.veevavault.com/ui/approved_viewer?token=7994-21c864d4-b928-49c5-b101-4d34e95f2be3. |